Revised spectral metrics for body surface measurements of gastric electrophysiology

Abstract

Background Electrogastrography (EGG) non-invasively evaluates gastric function but has not achieved common clinical adoption due to several technical limitations. Body Surface Gastric Mapping (BSGM) has been introduced to overcome these limitations, but pitfalls in traditional metrics used to analyze spectral data remain unaddressed. This study critically evaluates five traditional EGG metrics and introduces improved BSGM spectral metrics, with validation in a large cohort. Methods Pitfalls in five EGG metrics were assessed (dominant frequency, percentage time normogastria, amplitude, power ratio, and instability coefficient), leading to four revised BSGM spectral metrics. Traditional and revised metrics were compared to validate performance using a 100 BSGM subject database (30 min baseline; 4-hrs postprandial), recorded using Gastric Alimetry (Alimetry, New Zealand). Key Results BMI and amplitude were highly correlated (r=-0.57, p<0.001). We applied a conservative BMI correction to obtain a BMI-adjusted amplitude metric (r=-0.21, p=0.037). Instability coefficient was highly correlated with both dominant frequency (r=-0.44, p<0.001), and percent bradygastria (r=0.85, p<0.001), in part due to conflation of low frequency transients with gastric activity. This was corrected by introducing distinct gastric frequency and stability metrics (Principal Gastric Frequency and Gastric Alimetry Rhythm Index (GA-RI)) that were uncorrelated (r=0.14, p=0.314). Only 28% of subjects showed a maximal averaged amplitude within the first postprandial hour. Calculating Fed:Fasted Amplitude Ratio over a 4-hr postprandial window yielded a median increase of 0.31 (IQR 0-0.64) above the traditional ratio. Conclusions & Inferences The revised metrics resolve critical pitfalls impairing the performance of traditional EGG, and should be applied in future BSGM spectral analyses.

Competing Interest Statement

Conflicts of Interest GO hold grants and intellectual property in the field of GI electrophysiology and are members of University of Auckland spin-out companies: The Insides Company (GO), FlexiMap (PD), and Alimetry (GS, SC, SW, GO, and AG). CV and JE have no relevant conflicts to declare.

Funding Statement

This work was supported by the New Zealand Health Research Council and the Royal Australasian College of Surgeons' John Mitchell Crouch Fellowship.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was granted by the Auckland Health Research Ethics Committee (AH1130).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are available upon reasonable request at the discretion of the corresponding author.

留言 (0)

沒有登入
gif